| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.996 | 0.001 | 0.996 | Antipruritic | 0.996 0.001 DBMET00837 0.941 0.001 DBMET00883 | ||
| 0.996 | 0.001 | 0.996 | Hypoxia-inducible factor 1 alpha inhibitor | 0.996 0.001 DBMET00837 0.924 0.002 DBMET00883 | ||
| 0.994 | 0.003 | 0.994 | Antiinflammatory | 0.994 0.003 DBMET00837 0.989 0.003 DBMET00883 | ||
| 0.991 | 0.001 | 0.991 | Androgen agonist | 0.991 0.001 DBMET00837 0.864 0.001 DBMET00883 | ||
| 0.982 | 0.003 | 0.982 | Toll-Like receptor agonist | 0.982 0.003 DBMET00837 0.957 0.004 DBMET00883 | ||
| 0.981 | 0.003 | 0.981 | Toll-Like receptor 7 agonist | 0.981 0.003 DBMET00837 0.955 0.004 DBMET00883 | ||
| 0.965 | 0 | 0.965 | Arachidonic acid antagonist | 0.965 0 DBMET00837 0.656 0 DBMET00883 | ||
| 0.939 | 0.002 | 0.939 | Androgen antagonist | 0.939 0.002 DBMET00837 0.852 0.002 DBMET00883 | ||
| 0.899 | 0 | 0.899 | Glucocorticoid agonist | 0.899 0 DBMET00837 0.802 0.001 DBMET00883 | ||
| 0.867 | 0.009 | 0.914 | Transcription factor NF kappa B inhibitor | 0.867 0.009 DBMET00837 0.914 0.005 DBMET00883 | DBMET00883 | |
| 0.801 | 0 | 0.801 | Corticosteroid-like | 0.801 0 DBMET00837 0.582 0 DBMET00883 | ||
| 0.8 | 0.004 | 0.8 | Immunosuppressant | 0.8 0.004 DBMET00837 0.781 0.004 DBMET00883 | ||
| 0.753 | 0.001 | 0.753 | Glucocorticoid antagonist | 0.753 0.001 DBMET00837 0.697 0.001 DBMET00883 | ||
| 0.752 | 0 | 0.752 | Lipocortins synthesis agonist | 0.752 0 DBMET00837 0.526 0 DBMET00883 | ||
| 0.633 | 0.002 | 0.732 | Progesterone antagonist | 0.633 0.002 DBMET00837 0.732 0.001 DBMET00883 | DBMET00883 | |
| 0.626 | 0.002 | 0.636 | Interferon gamma antagonist | 0.626 0.002 DBMET00837 0.636 0.002 DBMET00883 | DBMET00883 | |
| 0.614 | 0.003 | 0.614 | Aromatase inhibitor | 0.614 0.003 DBMET00837 0.485 0.003 DBMET00883 | ||
| 0.605 | 0.004 | 0.682 | Interleukin 4 antagonist | 0.605 0.004 DBMET00837 0.682 0.003 DBMET00883 | DBMET00883 | |
| 0.577 | 0.002 | 0.603 | Lipocortins synthesis antagonist | 0.577 0.002 DBMET00837 0.603 0.002 DBMET00883 | DBMET00883 | |
| 0.499 | 0.004 | 0.499 | Cytokine production inhibitor | 0.499 0.004 DBMET00837 0.18 0.044 DBMET00883 | ||
| 0.53 | 0.066 | 0.611 | Apoptosis agonist | 0.53 0.066 DBMET00837 0.611 0.047 DBMET00883 | DBMET00883 | |
| 0.479 | 0.017 | 0.479 | Nitric oxide antagonist | 0.479 0.017 DBMET00837 0.479 0.017 DBMET00883 | ||
| 0.451 | 0.006 | 0.636 | NOS3 expression enhancer | 0.451 0.006 DBMET00837 0.636 0.004 DBMET00883 | DBMET00883 | |
| 0.427 | 0.037 | 0.427 | Immunomodulator | 0.427 0.037 DBMET00837 0.423 0.038 DBMET00883 | ||
| 0.374 | 0.027 | 0.427 | Sodium/bile acid cotransporter inhibitor | 0.374 0.027 DBMET00837 0.427 0.011 DBMET00883 | DBMET00883 | |
| 0.348 | 0.004 | 0.467 | Interleukin 5 antagonist | 0.348 0.004 DBMET00837 0.467 0.003 DBMET00883 | DBMET00883 | |
| 0.382 | 0.055 | 0.428 | Immunostimulant | 0.382 0.055 DBMET00837 0.428 0.042 DBMET00883 | DBMET00883 | |
| 0.332 | 0.024 | 0.525 | P-glycoprotein inhibitor | 0.332 0.024 DBMET00837 0.525 0.007 DBMET00883 | DBMET00883 | |
| 0.327 | 0.036 | 0.327 | DNA synthesis inhibitor | 0.327 0.036 DBMET00837 0.297 0.045 DBMET00883 | ||
| 0.386 | 0.099 | 0.386 | Cyclophilin D inhibitor | 0.386 0.099 DBMET00837 0.306 0.157 DBMET00883 | ||
| 0.307 | 0.028 | 0.307 | Hepatoprotectant | 0.307 0.028 DBMET00837 0.27 0.038 DBMET00883 | ||
| 0.247 | 0.002 | 0.371 | Anabolic | 0.247 0.002 DBMET00837 0.371 0.001 DBMET00883 | DBMET00883 | |
| 0.303 | 0.061 | 0.367 | Antioxidant | 0.303 0.061 DBMET00837 0.367 0.042 DBMET00883 | DBMET00883 | |
| 0.2 | 0.002 | 0.2 | Progesterone agonist | 0.2 0.002 DBMET00837 0.198 0.002 DBMET00883 | ||
| 0.188 | 0.004 | 0.188 | Mineralocorticoid receptor antagonist | 0.188 0.004 DBMET00837 0.187 0.004 DBMET00883 | ||
| 0.206 | 0.05 | 0.206 | Tumour necrosis factor antagonist | 0.206 0.05 DBMET00837 | ||
| 0.146 | 0.01 | 0.192 | T cell inhibitor | 0.146 0.01 DBMET00837 0.192 0.008 DBMET00883 | DBMET00883 | |
| 0.148 | 0.024 | 0.199 | Estrogen antagonist | 0.148 0.024 DBMET00837 0.199 0.013 DBMET00883 | DBMET00883 | |
| 0.163 | 0.042 | 0.163 | DNA polymerase I inhibitor | 0.163 0.042 DBMET00837 0.137 0.057 DBMET00883 | ||
| 0.122 | 0.004 | 0.124 | Nitric oxide donor | 0.122 0.004 DBMET00837 0.124 0.004 DBMET00883 | DBMET00883 | |
| 0.18 | 0.062 | 0.198 | Thrombolytic | 0.18 0.062 DBMET00837 0.198 0.053 DBMET00883 | DBMET00883 | |
| 0.172 | 0.054 | 0.204 | Lipid peroxidase inhibitor | 0.172 0.054 DBMET00837 0.204 0.04 DBMET00883 | DBMET00883 | |
| 0.143 | 0.062 | 0.173 | Ca2+-transporting ATPase inhibitor | 0.143 0.062 DBMET00837 0.173 0.011 DBMET00883 | DBMET00883 | |
| 0.098 | 0.018 | 0.14 | Estrogen agonist | 0.098 0.018 DBMET00837 0.14 0.012 DBMET00883 | DBMET00883 | |
| 0.118 | 0.038 | 0.124 | Antineoplastic alkaloid | 0.118 0.038 DBMET00837 0.124 0.036 DBMET00883 | DBMET00883 | |
| 0.12 | 0.043 | 0.131 | Toll-Like receptor 4 antagonist | 0.12 0.043 DBMET00837 0.131 0.034 DBMET00883 | DBMET00883 | |
| 0.101 | 0.031 | 0.101 | Na+ K+ transporting ATPase inhibitor | 0.101 0.031 DBMET00837 0.098 0.033 DBMET00883 | ||
| 0.06 | 0.011 | 0.068 | RNA-directed RNA polymerase stimulant | 0.06 0.011 DBMET00837 0.068 0.01 DBMET00883 | DBMET00883 | |
| 0.09 | 0.051 | 0.163 | Antineoplastic antibiotic | 0.09 0.051 DBMET00837 0.163 0.028 DBMET00883 | DBMET00883 | |
| 0.054 | 0.017 | 0.151 | 5-Alpha-reductase inhibitor | 0.054 0.017 DBMET00837 0.151 0.007 DBMET00883 | DBMET00883 | |
| 0.055 | 0.022 | 0.055 | Microtubule stabilization | 0.055 0.022 DBMET00837 0.052 0.025 DBMET00883 | ||
| 0.148 | 0.116 | 0.311 | Anesthetic general | 0.148 0.116 DBMET00837 0.311 0.03 DBMET00883 | DBMET00883 | |
| 0.029 | 0.001 | 0.068 | Transcortin receptor antagonist | 0.029 0.001 DBMET00837 0.068 0.001 DBMET00883 | DBMET00883 | |
| 0.043 | 0.018 | 0.073 | Glucose-6-phosphate dehydrogenase inhibitor | 0.043 0.018 DBMET00837 0.073 0.004 DBMET00883 | DBMET00883 | |
| 0.082 | 0.058 | 0.17 | Inducible nitric-oxide synthase inhibitor | 0.082 0.058 DBMET00837 0.17 0.012 DBMET00883 | DBMET00883 | |
| 0.095 | 0.075 | 0.111 | Estrogen receptor beta antagonist | 0.095 0.075 DBMET00837 0.111 0.044 DBMET00883 | DBMET00883 | |
| 0.121 | 0.102 | 0.153 | Farnesoid X receptor antagonist | 0.121 0.102 DBMET00837 0.153 0.049 DBMET00883 | DBMET00883 | |
| 0.14 | 0.126 | 0.272 | Interleukin antagonist | 0.14 0.126 DBMET00837 0.272 0.054 DBMET00883 | DBMET00883 | |
| 0.108 | 0.107 | 0.143 | Protein kinase stimulant | 0.108 0.107 DBMET00837 0.143 0.073 DBMET00883 | DBMET00883 | |
| 0.129 | 0.127 | 0.281 | Interleukin 6 antagonist | 0.129 0.127 DBMET00837 0.281 0.018 DBMET00883 | DBMET00883 | |
| 0.081 | 0.08 | 0.081 | Thioredoxin inhibitor | 0.081 0.08 DBMET00837 | ||
| 0.075 | 0.084 | 0.086 | Transcription factor NF kappa B stimulant | 0.086 0.057 DBMET00883 | DBMET00883 | |
| 0.019 | 0.029 | 0.046 | Estrogen receptor beta agonist | 0.046 0.02 DBMET00883 | DBMET00883 | |
| 0.022 | 0.033 | 0.031 | Estrogen receptor alpha agonist | 0.031 0.026 DBMET00883 | DBMET00883 | |
| 0.055 | 0.065 | 0.06 | Heme oxygenase stimulant | 0.06 0.047 DBMET00883 | DBMET00883 | |
| 0.015 | 0.027 | 0.022 | Estrone sulfatase inhibitor | 0.022 0.015 DBMET00883 | DBMET00883 | |
| 0.012 | 0.026 | 0.016 | Vitamin D receptor agonist | 0.016 0.013 DBMET00883 | DBMET00883 | |
| 0.013 | 0.029 | 0.038 | 5-Alpha-reductase 2 inhibitor | 0.038 0.008 DBMET00883 | DBMET00883 | |
| 0.057 | 0.079 | 0.159 | Topoisomerase II alpha inhibitor | 0.159 0.022 DBMET00883 | DBMET00883 | |
| 0.036 | 0.06 | 0.046 | Protein 50S ribosomal subunit inhibitor | 0.046 0.045 DBMET00883 | DBMET00883 | |
| 0.17 | 0.196 | 0.397 | Cholesterol antagonist | 0.397 0.05 DBMET00883 | DBMET00883 | |
| 0.069 | 0.104 | 0.106 | Topoisomerase I inhibitor | 0.106 0.065 DBMET00883 | DBMET00883 | |
| 0.182 | 0.222 | 0.247 | Interleukin 2 agonist | 0.247 0.122 DBMET00883 | DBMET00883 | |
| 0.007 | 0.051 | 0.015 | 5-Alpha-reductase 1 inhibitor | 0.015 0.013 DBMET00883 | DBMET00883 | |
| 0.033 | 0.078 | 0.143 | Aldosterone antagonist | 0.143 0.005 DBMET00883 | DBMET00883 | |
| 0.069 | 0.125 | 0.161 | Topoisomerase II inhibitor | 0.161 0.045 DBMET00883 | DBMET00883 | |
| 0.169 | 0.233 | 0.345 | Apoptosis antagonist | 0.345 0.058 DBMET00883 | DBMET00883 | |
| 0.059 | 0.139 | 0.095 | Expectorant | 0.095 0.074 DBMET00883 | DBMET00883 | |
| 0.101 | 0.184 | 0.136 | Melanin inhibitor | 0.136 0.103 DBMET00883 | DBMET00883 | |
| 0.065 | 0.149 | 0.163 | Cholesterol synthesis inhibitor | 0.163 0.039 DBMET00883 | DBMET00883 | |
| 0.084 | 0.179 | 0.196 | Angiogenesis stimulant | 0.196 0.096 DBMET00883 | DBMET00883 | |
| 0.093 | 0.19 | 0.133 | Platelet adhesion inhibitor | 0.133 0.127 DBMET00883 | DBMET00883 | |
| 0.052 | 0.15 | 0.094 | Estrogen receptor alpha antagonist | 0.094 0.031 DBMET00883 | DBMET00883 | |
| 0.024 | 0.134 | 0.096 | HIV-1 integrase (Strand Transfer) inhibitor | 0.096 0.024 DBMET00883 | DBMET00883 | |
| 0.059 | 0.177 | 0.096 | Alkylator | 0.096 0.093 DBMET00883 | DBMET00883 | |
| 0.092 | 0.265 | 0.183 | Neurotrophic factor enhancer | 0.183 0.094 DBMET00883 | DBMET00883 | |
| 0.041 | 0.215 | 0.114 | DNA intercalator | 0.114 0.062 DBMET00883 | DBMET00883 | |
| 0.079 | 0.261 | 0.126 | Adenylate cyclase stimulant | 0.126 0.11 DBMET00883 | DBMET00883 | |
| 0.019 | 0.209 | 0.076 | HIV-1 integrase (3'-Processing) inhibitor | 0.076 0.036 DBMET00883 | DBMET00883 | |
| 0.12 | 0.368 | 0.262 | Caspase 3 stimulant | 0.262 0.103 DBMET00883 | DBMET00883 | |
| 0.114 | 0.366 | 0.268 | Antibacterial | 0.268 0.161 DBMET00883 | DBMET00883 | |
| 0.056 | 0.346 | 0.171 | Aldehyde oxidase inhibitor | 0.171 0.122 DBMET00883 | DBMET00883 | |
| 0.138 | 0.443 | 0.331 | Caspase 9 stimulant | 0.331 0.162 DBMET00883 | DBMET00883 | |
| 0.051 | 0.408 | 0.164 | Tumour necrosis factor alpha release inhibitor | 0.164 0.14 DBMET00883 | DBMET00883 | |
| 0.008 | 0.613 | 0.159 | Diuretic | 0.159 0.07 DBMET00883 | DBMET00883 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |